Released Nov 1, 2017, after the close
10-Q filed Nov 1, 2017, 32 days after period end · 0001144204-17-055501
Q3 2017 · 10-Q
Revenue$2.66M$2.66M no prior Q3 2016 on file+12.7% vs Q2 2017
Net Income-$12.27M-$12.27M N/M vs Q3 2016N/M vs Q2 2017
EPS Diluted-$710.00-$710.00 N/M vs Q3 2016N/M vs Q2 2017
Operating Income-$12,450,180N/M
Operating Cash Flowderived-$10,957,614N/M
Free Cash Flowderived-$11,460,729N/M
Margins · derived
Operating margin-468.1%
Net margin-461.4%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $2.66M | — | — | — |
| Net Income | -$12.27M | -$11.57M | -$6.62M | -$11.02M |
| EPS Diluted | -$710.00 | -$0.67 | -$0.38 | -$1.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR